Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P11021 (
BiP
)
2,049
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Degradation of proteins that, because of improper or suboptimal processing, are retained in the endoplasmic reticulum (ER) involves retrotranslocation to reach the cytosolic ubiquitin-proteasome machinery. We found that substrates of this pathway, the precursor of human asialoglycoprotein receptor H2a and free heavy chains of murine class I major histocompatibility complex (MHC), accumulate in a novel preGolgi compartment that is adjacent to but not overlapping with the centrosome, the Golgi complex, and the ER-to-Golgi intermediate compartment (ERGIC). On its way to degradation, H2a associated increasingly after synthesis with the ER translocon Sec61. Nevertheless, it remained in the secretory pathway upon proteasomal inhibition, suggesting that its retrotranslocation must be tightly coupled to the degradation process. In the presence of proteasomal inhibitors, the ER chaperones calreticulin and calnexin, but not
BiP
, PDI, or glycoprotein glucosyltransferase, concentrate in the subcellular region of the novel compartment. The "quality control" compartment is possibly a subcompartment of the ER. It depends on microtubules but is insensitive to brefeldin A. We discuss the possibility that it is also the site for concentration and retrotranslocation of proteins that, like the mutant
cystic fibrosis transmembrane conductance regulator
, are transported to the cytosol, where they form large aggregates, the "aggresomes."
...
PMID:A novel quality control compartment derived from the endoplasmic reticulum. 1140 79
Almost all secreted proteins pass through the endoplasmic reticulum (ER), an organelle that is equipped to tolerate and/or degrade misfolded proteins. We report here that yeast expressing the
cystic fibrosis transmembrane conductance regulator
(
CFTR
) concentrate the protein at defined sites in the ER membrane that are not necessarily enriched for the ER molecular chaperone
BiP
. We propose that these sites are Russell bodies, an ER subcompartment in which misfolded proteins are stored and can be targeted for degradation.
...
PMID:Localization of the BiP molecular chaperone with respect to endoplasmic reticulum foci containing the cystic fibrosis transmembrane conductance regulator in yeast. 1264 34
The unfolded protein response (UPR) is a cellular recovery mechanism activated by endoplasmic reticulum (ER) stress. The UPR is coordinated with the ER-associated degradation (ERAD) to regulate the protein load at the ER. In the present study, we tested how membrane protein biogenesis is regulated through the UPR in epithelia, using the
cystic fibrosis transmembrane conductance regulator
(
CFTR
) as a model. Pharmacological methods such as proteasome inhibition and treatment with brefeldin A and tunicamycin were used to induce ER stress and activate the UPR as monitored by increased levels of spliced XBP1 and
BiP
mRNA. The results indicate that activation of the UPR is followed by a significant decrease in genomic
CFTR
mRNA levels without significant changes in the mRNA levels of another membrane protein, the transferrin receptor. We also tested whether overexpression of a wild-type
CFTR
transgene in epithelia expressing endogenous wild-type
CFTR
activated the UPR. Although
CFTR
maturation is inefficient in this setting, the UPR was not activated. However, pharmacological induction of ER stress in these cells also led to decreased endogenous
CFTR
mRNA levels without affecting recombinant
CFTR
message levels. These results demonstrate that under ER stress conditions, endogenous
CFTR
biogenesis is regulated by the UPR through alterations in mRNA levels and posttranslationally by ERAD, whereas recombinant
CFTR
expression is regulated only by ERAD.
...
PMID:Endoplasmic reticulum stress and the unfolded protein response regulate genomic cystic fibrosis transmembrane conductance regulator expression. 1700 2
F508del-
CFTR
, the most common mutation of the
cystic fibrosis transmembrane conductance regulator
(
CFTR
) protein, disrupts intracellular trafficking leading to cystic fibrosis (CF). The trafficking defect of F508del-
CFTR
can be rescued by simultaneous inactivation of its four RXR motifs (4RK). Proteins involved in the F508del-
CFTR
trafficking defect and/or rescue are therefore potential CF therapeutic targets. We sought to identify these proteins by investigating differential proteome modulation in BHK cells over-expressing wt-
CFTR
, F508del-
CFTR
or the revertant F508del/4RK-
CFTR
. By 2-dimensional electrophoresis-based proteomics and western blot approaches we demonstrated that over-expression of F508del/4RK-
CFTR
modulates the expression of a large number of proteins, many of which are reported interactors of
CFTR
and/or 14-3-3 with potential roles in
CFTR
trafficking. GRP78/
BiP
, a marker of ER stress and unfolded protein response (UPR), is up-regulated in cells over-expressing either F508del-
CFTR
or F598del/4RK-
CFTR
. However, over-expression of F508del/4RK-
CFTR
induces the up-regulation of many other UPR-associated proteins (e.g. GRP94, PDI, GRP75/mortalin) and, interestingly, the down-regulation of proteasome components associated with
CFTR
degradation, such as the proteasome activator PA28 (PSME2) and COP9 signalosome (COPS5/CSN5). Moreover, the F508del-
CFTR
-induced proteostasis imbalance, which involves some heat shock chaperones (e.g. HSP72/Hpa2), ER-EF-hand Ca(2+)-binding proteins (calumenin) and the proteasome activator PA28 (PSME2), tends to be 'restored', i.e., in BHK cells over-expressing F508del/4RK-
CFTR
those proteins tend to have expression levels similar to the wild-type ones. These findings indicate that a particular cellular environment orchestrated by the UPR contributes to and/or is compatible with F508del/4RK-
CFTR
rescue.
...
PMID:Rescue of F508del-CFTR by RXR motif inactivation triggers proteome modulation associated with the unfolded protein response. 2004 41